Manufacturing / Pharmaceutical Preparations
Apellis Pharmaceuticals, Inc.
APLS
$41.04
+$0.01 (+0.02%)
Price as of Aug 5, 2026 00:02 UTC
5.3 B
Market Cap (Mid Cap)
Technical Signals
as of May 13
Bullish
5 of 7
Trend
- Above 20-day average $39.96
- Above 50-day average $34.93
- Above 200-day average $26.70 ยท +53.7%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) 28d ago
- Momentum cross (20/50) 29d ago
Volume
- Elevated volume 16.5x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for APLS options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
46 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Apr 29, 2026 | Baumal Caroline | Gift | 900 | $0 | |
| Apr 17, 2026 | Sullivan Timothy Eugene | Gift | 11,096 | $0 | |
| Apr 17, 2026 | Sullivan Timothy Eugene | Gift | 11,096 | $0 | |
| Apr 06, 2026 | O'Brien Stephanie Monaghan | Other | 5,750 | $0 | |
| Mar 11, 2026 | Francois Cedric | Gift | 64,869 | $0 | |
| Mar 11, 2026 | Francois Cedric | Gift | 64,869 | $0 | |
| Feb 27, 2026 | Dolsten Mikael | Grant | 24,135 | $505,870 | |
| Feb 27, 2026 | Dolsten Mikael | Grant | 14,312 | $0 | |
| Feb 11, 2026 | DeLong Mark Jeffrey | Sell | 368 | $8,153 | |
| Feb 03, 2026 | Francois Cedric | Exercise | 8,840 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Dec 31, 2025 | Q4 2025 | -$0.39 | -$0.47 | -21.0% | Miss |
| Sep 30, 2025 | Q3 2025 | $1.21 | $1.67 | +38.1% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.48 | -$0.33 | +31.0% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.37 | -$0.74 | -101.4% | Miss |
Track APLS with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for APLS and your entire portfolio.